Form 4: CME Group Director Receives Stock Grant
Statement of Changes in Beneficial Ownership
Dennis Suskind, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.
Summary
- Dennis Suskind, a Director of CME Group Inc., was granted 645 shares of Class A Common Stock on June 25, 2026.
- This grant is part of the company's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.
- The shares are fully vested and not subject to any further vesting conditions.
- Following this transaction, Suskind beneficially owns 3,344 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director compensation event rather than a significant strategic or financial development.
Positives
- Director compensation through equity awards aligns management interests with shareholders.
- The grant of fully vested shares indicates immediate value realization for the director.
- The transaction is part of a pre-established annual compensation program, suggesting a predictable and structured approach to director remuneration.
Future Outlook
This filing pertains to a past transaction and does not contain forward-looking statements or guidance regarding future company performance.
Industry Context
StockSavvy.ai notes that equity compensation for directors is a common practice in the financial services and exchange industry, aimed at attracting and retaining experienced leadership while aligning their incentives with long-term shareholder value.
Stakeholder Impact
- Shareholders: The transaction reflects a standard component of director compensation, which is a known cost of doing business. The alignment of director interests through equity can be viewed positively.
- Employees: This filing does not directly impact employees, but it is part of the overall compensation structure of the company.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/06/2026 | Date of execution for the Power of Attorney document. |
| 06/25/2026 | Transaction date for the acquisition of Class A Common Stock. |
| 06/29/2026 | Date of signature for the Form 4 filing. |
Keywords
CME Group, Form 4, Director Compensation, Equity Award, Stock Grant, Class A Common Stock, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.